Skip to main content
. Author manuscript; available in PMC: 2019 Feb 19.
Published in final edited form as: J Alzheimers Dis. 2018;64(Suppl 1):S161–S189. doi: 10.3233/JAD-179939

Fig. 3.

Fig. 3.

Cohort studies generating ante- and post-mortem biospecimens which are used to generate multi-layered omics data. These data feed a systems biology computation pipeline for therapeutic target nomination. There are two stages of functional validation, one with targeted proteomics using brain tissue from the same cases and the other with a variety of high throughput ex vivo models. High value targets will then move to small molecule drug screen and eventual drug selection.